Saez de Gordoa Karmele, Tasso Elias, Rei Alexandre, Ramonda Martin, Salinas Belinda, Cobo-Lopez Sandra, Orois Aida, Cobo Amparo, Manyalich-Blasi Marti, Ramón Y Cajal Teresa, Mora Mireia, Hanzu Felicia, Vidal Pérez Oscar, Rodrigo-Calvo Maria Teresa
Pathology Department, Centre of Biomedical Diagnosis, Hospital Clínic, 08036 Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Cancers (Basel). 2025 Jun 17;17(12):2021. doi: 10.3390/cancers17122021.
: Given the high incidence and generally favorable prognosis of papillary thyroid microcarcinomas (PTMs), the Porto Proposal aims to refine the management of these tumors. It designates tumors lacking certain risk factors as papillary microtumors (PMTs) to avoid overtreatment and reduce patient stress. The updated Porto Proposal (uPp) suggests criteria for reclassifying incidental PTMs as PMTs. This study seeks to validate these criteria using data from a university hospital in Catalonia, Spain, and assess the clinical and pathological characteristics of PTMs. : This retrospective study analyzed patients diagnosed with PTM (≤1 cm) at a university hospital from 2000 to 2024. The study examined variables, including lymph node positivity, incidental diagnosis, tumor location, histological type, treatment, multifocality, age at diagnosis, tumor size, and survival. The uPp criteria were applied to reclassify PTMs into PMTs or PMCs (true papillary microcarcinomas). Student's -test and chi-square tests were used to evaluate the associations between these variables and the uPp classification. : The cohort comprised 107 patients, with 77 (72%) women and 30 men. The mean age at diagnosis was 54.5 years. Out of the total, 77 (72%) cases were reclassified as PMTs and 30 (28%) as PMCs according to the uPp criteria. PMC tumors were larger (mean size 4.5 mm vs. 3.3 mm for PMT, = 0.014) and were significantly associated with multifocality (52.2%; = 0.004). Most lymph node-positive cases were classified as PMCs (69.2%; < 0.001) and were multifocal and bilateral more commonly. However, no significant differences in outcomes between PMCs and PMTs were found ( = 0.188). Follicular histology was significantly more common in PMTs (87.0%, < 0.001) and rarely had lymph node metastases (4.6%; = 0.047). : The updated Porto Proposal (uPp) effectively identifies PTMs with minimal malignant potential, distinguishing between PMT and PMC. The findings support the protocol's use in reducing unnecessary treatments and psychological stress for patients. The study highlights significant clinical and pathological differences between PTM subtypes, reinforcing the protocol's applicability in daily pathological practice.
鉴于甲状腺乳头状微小癌(PTMs)的高发病率和总体良好预后,《波尔图建议》旨在优化这些肿瘤的管理。它将缺乏某些风险因素的肿瘤指定为乳头状微肿瘤(PMTs),以避免过度治疗并减轻患者压力。更新后的《波尔图建议》(uPp)提出了将偶然发现的PTMs重新分类为PMTs的标准。本研究旨在利用西班牙加泰罗尼亚一家大学医院的数据验证这些标准,并评估PTMs的临床和病理特征。
这项回顾性研究分析了2000年至2024年在一家大学医院被诊断为PTM(≤1 cm)的患者。该研究考察了多个变量,包括淋巴结阳性、偶然诊断、肿瘤位置、组织学类型、治疗、多灶性、诊断时年龄、肿瘤大小和生存率。应用uPp标准将PTMs重新分类为PMTs或PMC(真正的乳头状微小癌)。采用学生t检验和卡方检验来评估这些变量与uPp分类之间的关联。
该队列包括107名患者,其中77名(72%)为女性,30名为男性。诊断时的平均年龄为54.5岁。根据uPp标准,总共77例(72%)病例被重新分类为PMTs,30例(28%)为PMCs。PMC肿瘤更大(平均大小4.5 mm,而PMT为3.3 mm,P = 0.014),并且与多灶性显著相关(52.2%;P = 0.004)。大多数淋巴结阳性病例被分类为PMCs(69.